Brilinta Approved for Acute Coronary Syndromes (HealthDay)

HealthDay – THURSDAY, July 21 (HealthDay News) — Brilinta (ticagrelor) has
been approved by the U.S. Food and Drug Administration to help reduce the
risk of heart attack and cardiovascular death among people with acute
coronary syndromes (ACS).